Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ebrantil

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Aim. To evaluate the clinical efficacy of ebrantil used in patients with resistant arterial hypertension (RAH) in Stage lll-V… Expand
Is this relevant?
2012
2012
The developing callus requires sufficient oxygen and substrate supply. Despite the importance of these processes, we have limited… Expand
  • figure 1
  • figure 2
  • table 1
  • table 4
  • table 5
Is this relevant?
2012
2012
AIM To evaluate the clinical efficacy of ebrantil used in patients with resistant arterial hypertension (RAH) in Stage III-V… Expand
Is this relevant?
2010
2010
Different bones have different blood supplies, which may influence bone healing. Therefore, elucidation of the mechanisms… Expand
Is this relevant?
1996
1996
Urapidil, a new alpha-blocker that peripherally antagonizes postsynaptic alpha 1 receptors and centrally causes a reduction in… Expand
Is this relevant?
1995
1995
From before treatment throughout its course a new hypotensive drug ebrantil was studied for clinical efficacy in 52 patients with… Expand
Is this relevant?
1990
1990
In 10 patients on chronic haemodialysis treatment for terminal renal failure with hypertension urapidil (Ebrantil) was given in… Expand
Is this relevant?
1990
1990
In a cross-over study, the effect of 25 mg urapidil infusion (U, Ebrantil 25, Byk-Gulden, FRG) on serotonin (5HT) metabolism and… Expand
Is this relevant?
1986
1986
Ebrantil has been added to the beta-blockers and/or diuretics in the treatment of 32 patients with moderate and severe… Expand
Is this relevant?
1981
1981
The vasodilating effect of 6-(3-[4-(o-methoxy-phenyl)-piperazin-1-yl]-propylamino)-1,3-dimethyluracil (urapidil, Ebrantil) and… Expand
Is this relevant?